These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30746966)
1. Synthesis and biological evaluation of 3-arylcoumarins as potential anti-Alzheimer's disease agents. Yang J; Zhang P; Hu Y; Liu T; Sun J; Wang X J Enzyme Inhib Med Chem; 2019 Dec; 34(1):651-656. PubMed ID: 30746966 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 3-arylbenzofuranone derivatives as potential anti-Alzheimer's disease agents. Yang J; Yun Y; Miao Y; Sun J; Wang X J Enzyme Inhib Med Chem; 2020 Dec; 35(1):805-814. PubMed ID: 32183602 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 4-arylcoumarins as potential anti-Alzheimer's disease agents. Yun Y; Yang J; Miao Y; Wang X; Sun J Bioorg Med Chem Lett; 2020 Feb; 30(4):126900. PubMed ID: 31882295 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease. Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease. Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289 [TBL] [Abstract][Full Text] [Related]
6. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents. Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731 [TBL] [Abstract][Full Text] [Related]
7. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease. Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease. Sang Z; Wang K; Shi J; Liu W; Tan Z Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of 4'-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer's disease. Xiao G; Li Y; Qiang X; Xu R; Zheng Y; Cao Z; Luo L; Yang X; Sang Z; Su F; Deng Y Bioorg Med Chem; 2017 Feb; 25(3):1030-1041. PubMed ID: 28011206 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease. Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252 [TBL] [Abstract][Full Text] [Related]
11. 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. Secci D; Carradori S; Petzer A; Guglielmi P; D'Ascenzio M; Chimenti P; Bagetta D; Alcaro S; Zengin G; Petzer JP; Ortuso F J Enzyme Inhib Med Chem; 2019 Dec; 34(1):597-612. PubMed ID: 30727777 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease. Sang Z; Song Q; Cao Z; Deng Y; Zhang L J Enzyme Inhib Med Chem; 2022 Dec; 37(1):69-85. PubMed ID: 34894968 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and in vitro evaluation of 4-aminoalkyl-1(2H)-phthalazinones as potential multifunctional anti-Alzheimer's disease agents. Ye C; Xu R; Cao Z; Song Q; Yu G; Shi Y; Liu Z; Liu X; Deng Y Bioorg Chem; 2021 Jun; 111():104895. PubMed ID: 33887586 [TBL] [Abstract][Full Text] [Related]
15. Flurbiprofen-chalcone hybrid Mannich base derivatives as balanced multifunctional agents against Alzheimer's disease: Design, synthesis and biological evaluation. Tian C; Qiang X; Song Q; Cao Z; Ye C; He Y; Deng Y; Zhang L Bioorg Chem; 2020 Jan; 94():103477. PubMed ID: 31818478 [TBL] [Abstract][Full Text] [Related]
16. Multitarget drug design strategy against Alzheimer's disease: Homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties. Li Y; Qiang X; Luo L; Yang X; Xiao G; Zheng Y; Cao Z; Sang Z; Su F; Deng Y Bioorg Med Chem; 2017 Jan; 25(2):714-726. PubMed ID: 27923535 [TBL] [Abstract][Full Text] [Related]
18. Cyanobiphenyls: Novel H Godyń J; Zaręba P; Łażewska D; Stary D; Reiner-Link D; Frank A; Latacz G; Mogilski S; Kaleta M; Doroz-Płonka A; Lubelska A; Honkisz-Orzechowska E; Olejarz-Maciej A; Handzlik J; Stark H; Kieć-Kononowicz K; Malawska B; Bajda M Bioorg Chem; 2021 Sep; 114():105129. PubMed ID: 34217977 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 3-(4-aminophenyl)-coumarin derivatives as potential anti-Alzheimer's disease agents. Hu YH; Yang J; Zhang Y; Liu KC; Liu T; Sun J; Wang XJ J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1083-1092. PubMed ID: 31117844 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease. Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]